HIV-HCV RNA loads and liver failure in coinfected patients with coagulopathy

Haematologica

Volumn 84, Issue 6, 1999, Pages 525-529

  Dragoni, Francesco ^a   Cafolla, Arturo ^a   Gentile, Giuseppe ^a   Mazzucconi, Maria Gabriella ^a   Vella, Stefano ^b   Di Corpo, Ulisse ^c   Tosti, Maria Elena ^b   Pisani, Giulio ^b   Donato, Vittorio ^a   Martino, Pietro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c Dicosoft Statistical Company   (Italy)

Author keywords

Coagulopathy patients; Coinfection; HCV RNA load; HIV RNA load; Liver failure

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; RNA ANALYSIS; VIREMIA;

ADULT; ALANINE TRANSAMINASE; BLOOD COAGULATION DISORDERS; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; LIVER; LIVER FAILURE; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; ORGAN SIZE; PORTAL VEIN; RNA, VIRAL; SPLEEN;

EID: 0032995925     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J AIDS 1993; 12:602-10.
2. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haenophilic patients. Br J Haematol 1994; 87:555-61.
3. Dragoni F, Mazzucconi MG, Cafolla A, Gentile G, Peraino M, Gonzalez M. Rapid liver failure related to chronic C hepatitis in an HIV positive hemophilic patients with severe immunodepression. Haematologica 1996; 81:335-8.
4. Makris M, Preston FE, Rosendaal FR, Underwood JCE, Rice KM, Triger DR. The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol 1996; 94:746-52.
5. Thomas DL, Shih JW, Alter HJ, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996; 174: 690-5.
6. Brettler DB, Alter HJ, Dienstag J, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 1990; 76:254-6.
7. Garson JA, Tuke PW, Makris M, et al. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus contaminated factorVIII concentrates. Lancet 1990; 336:1022-5.
8. Simmonds P, Zhang LQ, Watson HG, et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs and drug users. Lancet 1990; 336: 1469-72.
9. Triger DR, Preston FE. Chronic liver disease in haemophiliacs. Br J Haematol 1990; 74:241-5.
10. Sherman KE, O'Brien J, Gutierrez AG, et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 1993; 31:2679-82.
11. Lau JYN, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341:1501-4.
12. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in haemophiliacs: Relationship to human immunodeficiency virus infection and liver disease. Blood 1994; 84:1020-3.
13. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70.
14. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4 lymphocytes counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996; 334:426-31.
15. Carpenter CCJ, Fischl MA, Hammer SM, et al. Anti-retroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA Panel. JAMA 1997; 277:1962-9.
16. Chiarotti F, Palombi M, Schinaia N, Ghirardini A, Bellocco R. Median time from seroconversion to AIDS in Italian HIV-positive haemophiliacs: Different parametric estimates. Stat Med 1994; 13:163-75.
17. Chiarotti F, Palombi M, Schinaia N, Ghirardini A, Prospero L Effects of different parametric estimates of seroconversion time on analysis of progression to AIDS among Italian HIV-positive haemophiliacs. Stat Med 1992; 11:591-601.
18. Sanchez-Quijano A, Andreu J, Gavilan F, et al. Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. Eur J Clin Microbiol Infect Dis 1995; 14:949-53.
19. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26:1-5.
20. Di Lelio L, Cestari C, Lomazzi A, Beretta L Cirrhosis: diagnosis with sonographic study of liver surface. Radiology 1983; 172:389-92.
21. Gaiani S, Gramantieri L, Venturoli N, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study com paring ultrasonography and percutaneous liver biopsy. J Hepatol 1997; 27:979-85.
22. Bukh J, Miller R. Diagnostic and clinical implications of the different genotypes of hepatitis C virus. Hepatology 1994; 20:256-9.
23. Samaniego JG, Soriano V, Castilla J, et al. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. Am J Gastroenterol 1997; 92:1130-4.
24. Cribier B, Schmitt C, Rey D. HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype. Res Virology 1997; 148:267-71.
25. Jarvis LM, Ludlam CA, Ellender JA, et al. Investigation of the relative infectivity and pathogenicity of different hepatitis C virus genotypes in haemophiliacs. Blood 1996; 87:3007-11.
26. Sherman KE, Freeman S, Harrison S, Andron L. Prevalence of antibody to hepatitis C virus in patients infected with the human immunodeficiency virus. J Infect Dis 1991; 163:414-5.
27. Bonacini M, Ding L, Govindarajan S. HIV+HCV coinfectiori: comparison with HCV infection. Hepatology 1994; 20:A333.
28. Lau JYN, Mikozami M, Ohno T, Diamond DA, Kniffen J, Davis GL. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. Lancet 1993; 342:1208-9.
29. Hanley JP, Jarvis LM, Andrews J, et al. Interferon treatment for chronic hepatitis C infection in hemophiliacs: Influence of virus load, genotype and liver pathology on response. Blood 1996; 87:1704-9.
30. Vento S, Carofano T, Renzini C, Casali F, Ferraro T, Concia E. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. AIDS 1998; 12:116-7.
31. Rutschmann OT, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis 1998; 177:783-5.
32. Rockstroh JK, Theisen A, Kaiser R, Sauerbruck T, Spengler U. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs. AIDS 1998; 12:829-30.